Search Results
Found 1 results
510(k) Data Aggregation
(190 days)
The CareSens Pen Needle and Softip Pen Needle are intended for use with pen injector devices for subcutaneous injection of fluids, including insulin and exenatide.
CareSens Pen Needle and Softip Pen Needle are sterile, non-pyrogenic, single-use injection needles intended for use with injection pens. This needle is a device for subcutaneous injection of medicines such as insulin and exenatide used with pen injectors for subcutaneous injection. CareSens Pen Needle and Softip Pen Needle are the same product in exception to the brand name.
The provided text describes the 510(k) premarket notification for the "CareSens Pen Needle and Softip Pen Needle". It focuses on demonstrating substantial equivalence to a predicate device and a reference device, primarily through bench testing and biocompatibility assessments, rather than human clinical studies involving AI.
Therefore, many of the requested categories related to medical AI device studies, such as sample size for test/training sets, data provenance, number/qualification of experts, adjudication methods, MRMC studies, standalone performance, and ground truth for training, are not applicable or cannot be extracted from this document as the device in question is a physical medical needle, not an AI device.
Here's the information that can be extracted related to acceptance criteria and performance, as appropriate for this type of medical device:
1. Table of Acceptance Criteria and Reported Device Performance
| Test Item | Acceptance Criteria (Standard Reference) | Reported Device Performance |
|---|---|---|
| Performance Bench Tests (ISO 11608-2:2012) | ||
| Dimension testing | ISO 11608-2:2012 (4.2 Dimensions / 4.2.1 General / 4.2.2 Dimensions for needles), meets requirements | Meets requirements |
| Flow rate testing | ISO 11608-2:2012 (4.3 Determination of flow rate through the needle), meets requirements | Meets requirements |
| Bond between hub and needle tube testing | ISO 11608-2:2012 (4.4 Bond between hub and needle tube), meets requirements | Meets requirements |
| Needle point freedom from defects lubrication test | ISO 11608-2:2012 (4.5 Needle point / 4.6 Freedom from defects / 4.7 Lubrication), meets requirements | Meets requirements |
| Dislocation of measuring point at patient end | ISO 11608-2:2012 (4.8 Dislocation of measuring point at patient end), meets requirements | Meets requirements |
| Compatibility of needles and injector system test / Ease of assembly and disassembly | ISO 11608-2:2012 (4.9 Determination of functional compatibility with needle-based injection systems / 4.10 Ease of assembly and disassembly), meets requirements | Meets requirements |
| Biocompatibility Tests (ISO 10993) | ||
| Cytotoxicity test | ISO 10993-5, Tests for in vitro Cytotoxicity, Test on extracts | Non-Cytotoxic |
| Intracutaneous (Intradermal) Reactivity Test | ISO 10993-10, Intracutaneous(Intradermal) reactivity test | Negligible |
| Sensitization Test (Guinea pig maximization test) | ISO 10993-10, Sensitization(Guinea pig maximization test) | Weak sensitizer |
| Acute systemic toxicity test | ISO 10993-11, Acute systemic toxicity | Non-toxic |
| Pyrogen test | ISO 10993-11, USP Rabbit Pyrogen Test | Non-pyrogenic |
| Haemolysis test | ISO 10993-4, Haemolysis testing-general considerations | Non-hemolytic |
| Sterilization Tests | ||
| Packaging | Packaging should keep clean from microorganism and not be broken before use; needle packed one by one. | PASS |
| Sterility Test-Direct inoculation | The Korean pharmacopoeia Tenth edition (same as USP 25 sterility test) | PASS |
| Ethylene oxide sterilization residuals | ISO 10993-7: EO ≤4 mg first 24 hrs and ECH ≤9 mg first 24 hrs for limited exposure ( |
Ask a specific question about this device
Page 1 of 1